FREE Shippingto US, AU, UK and EU on all orders over $149
/

Chondroxide 5% 30g gel (topical application)

$32.70

d70426774431

Description

The instruction for medical use

of Hondroksid Torgovoye medicine a name

Hondroksid

Mezhdunarodnoye the unlicensed name

Is not present

the Dosage form

Gel for external use of 5%

Structure

of 1 g of gel

sodium sulfate (in terms of 100% dry matter) 0.05 g,

excipients a dimethyl sulfoxide, propylene glycol, isopropanol, ethanol, sodium disulphite, methylparahydroxybenzoate, propilparagidroksibenzoat, carbomer, fragrance orange, the water purified contains active agent of chondroitin.

The description

Yellowish translucent uniform gel with a fruit smell

Pharmacotherapeutic group

Other drugs for topical treatment of diseases of the musculoskeletal system

the ATX M02AX Code

the Pharmacological

Pharmacokinetics properties

Hondroksid, gel is well soaked up. The dimethyl sulfoxide promotes the best penetration of chondroitin of sulfate through cellular membranes deep into of fabrics. Chondroitin sulfate after putting drug on skin quickly and selectively comes to a joint with achievement of the maximum concentration in 30 minutes and the subsequent two-phase removal of drug from cartilaginous tissue. End of a fast phase of removal happens in 1 hour after use. Time of deduction of drug in a joint is 5 hours.

The pharmacodynamics

Hondroksid, gel possesses the combined action slows down progressing of an osteoarthrosis and osteochondrosis, has anesthetic, anti-inflammatory effect, stimulates recovery of an articulate cartilage, improves mobility and reduces a swelling of joints.

Thanks to an optimum combination of components of gel mutual strengthening of their anesthetic and anti-inflammatory effects is noted. Drug use Hondroksid, gel allows to lower a dose of non-steroidal anti-inflammatory drugs.

Hondroksid, gel contains a natural component of chondroitin sulfate (high-molecular mucopolysaccharide) which takes part in creation of cartilaginous tissue. Chondroitin sulfate improves phosphorus-calcium exchange in cartilaginous tissue, reduces activity of the enzymes destroying cartilaginous tissue, slows down processes of a degeneration (destruction) of cartilaginous tissue, stimulates synthesis of glucosaminoglycans, interferes with collapse of connective tissue. It leads to reduction of morbidity and increase in mobility of the affected joints.

Indications

– degenerative dystrophic diseases of peripheral joints and a backbone (osteoarthrosis, including an osteoarthrosis of a temporal and mandibular joint, a spondylarthrosis, osteochondrosis, osteoporosis, heyropatiya).

Route of administration and doses

Outwardly. Hondroksid, gel is applied by 2-3 times a day to skin over the center of defeat and easily rub the patting movements within 2-3 minutes before full absorption. A course of treatment – from 2-3 weeks to 2-3 months. If necessary the course of treatment is repeated.

Side effects

– allergic reactions

of the Contraindication

– hypersensitivity to drug components

– damage of integuments in the field of drawing

Special instructions

It is necessary to avoid hit of drug on mucous membranes and open wounds.

At hit on skin or clothes gel easily washes off, without leaving marks.

Children’s age

the Efficiency and safety of use of Hondroksid at children’s age are not established.

Pregnancy and a lactation

Efficiency and safety of use of Hondroksid during pregnancy and a lactation are not established.

The feature of influence of medicine on ability to drive the car or potentially dangerous mechanisms

does not influence ability to run the vehicle or potentially dangerous mechanisms.

Overdose

About drug overdose cases Hondroksid, gel it was not reported.

A form of release and packing

On 30 g in tubas aluminum or polyethylene laminatny.

Each tuba together with the instruction for medical use in the state and Russian languages is placed in a pack from cardboard.

To Store storage conditions at

a temperature not higher than 25 S. Hranit out of children’s reach!

2 years

not to apply a period of storage after an expiration date.

Prescription status

Without prescription

JSC Nizhpharm Producer,

Russian Federation 603950, Nizhny Novgorod, GSP-459, Salganskaya St., 7

ph.: (831) 278-80-88

fax: (831) 430-72-28

a web the website: http://www.nizhpharm.ru

the Name and the country of the owner of the registration certificate

of JSC Nizhpharm, the Russian Federation

The address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods)

Representative office of JSC Nizhpharm

050043, Republic of Kazakhstan, Almaty, mdt. Khan-Taniri, 55b

ph.: (727) 398-64-91, 398-64-92, 398-64-93, 243-45-03, 243-45-04

fax: (727) 398-64-95

email: almaty@stada.kz

Additional information

Ingredient

Reviews

There are no reviews yet.

Be the first to review “Chondroxide 5% 30g gel (topical application)”

Your email address will not be published.